HEATHER DUPLECHAIN: Open Payments
NPI 1053898403 · CROWLEY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 37 payments from 9 companies in 2025. Trend: 2023 $488 · 2024 $908 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $184 |
| Janssen Pharmaceuticals, Inc | 8 | $153 |
| ABBVIE INC. | 10 | $150 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
| Vanda Pharmaceuticals Inc. | 3 | $45 |
| Alkermes, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $18 |
Products named: Auvelity, INVEGA SUSTENNA, VRAYLAR, COBENFY, CAPLYTA, REXULTI, FANAPT, ARISTADA.
Industry payments across LA — which companies pay providers there.
